TGFβ signaling in cartilage development and maintenance

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 102, Issue 1, 2014, Pages 37-51

  Wang, Weiguang ^a   Rigueur, Diana ^a   Lyons, Karen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cartilage; Development; Maintenance; Signaling; TGF

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN; CELL ADHESION MOLECULE; COLLAGENASE 3; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE P38; MUELLERIAN INHIBITING FACTOR; MYOSTATIN; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEVELOPMENT; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GROWTH PLATE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE REGENERATION; UPREGULATION; ANIMAL; CARTILAGE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARTILAGE; CHONDROGENESIS; HUMANS; MICE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84896928871     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21058     Document Type: Article

References (132)

1. Akiyama H, Lefebvre V. 2011. Unraveling the transcriptional regulatory machinery in chondrogenesis. J Bone Miner Metab 29:390-395.
2. Alarcon C, Zaromytidou AI, Xi Q, et al. 2009. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139:757-769.
3. Alvarez J, Sohn P, Zeng X, et al. 2002. TGFβ2 mediates the effects of Hedgehog on hypertrophic differentiation and PTHrP expression. Development 129:1913-1924.
4. Azhar M, Yin M, Bommireddy R, et al. 2009. Generation of mice with a conditional allele for transforming growth factor beta 1 gene. Genesis 47:423-431.
5. Baffi MO, Slattery E, Sohn P, et al. 2004. Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev Biol 276:124-142.
6. Ballock RT, Heydemann A, Wakefield LM, et al. 1993. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: Regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 158:414-429.
7. Barry F, Boynton RE, Liu B, et al. 2001. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268:189-200.
8. Beier F, Loeser RF. 2010. Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J Cell Biochem 110:573-580.
9. Benazet JD, Pignatti E, Nugent A, et al. 2012. Smad4 is required to induce digit ray primordia and to initiate the aggregation and differentiation of chondrogenic progenitors in mouse limb buds. Development 139:4250-4260.
10. Bernabeu C, Lopez-Novoa JM, Quintanilla M. 2009. The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 1792:954-973.
11. Billiar RB, St Clair JB, Zachos NC, et al. 2004. Localization and developmental expression of the activin signal transduction proteins Smads 2, 3, and 4 in the baboon fetal ovary. Biol Reprod 70:586-592.
12. Billinghurst RC, Dahlberg L, Ionescu M, et al. 1997. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Investig 99:1534-1545.
13. Blaney Davidson EN, Remst DF, et al. 2009. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 182:7937-7945.
14. Burks TN, Cohn RD. 2011. Role of TGF-beta signaling in inherited and acquired myopathies. Skelet Muscle 1:19.
15. Chen CG, Thuillier D, Chin EN, et al. 2012. Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis. Arthritis Rheum 64:3278-3289.
16. Chu GC, Dunn NR, Anderson DC, et al. 2004. Differential requirements for Smad4 in TGF beta-dependent patterning of the early mouse embryo. Development 131:3501-3512.
17. Clancy R, Rediske J, Koehne C, et al. 2001. Activation of stress-activated protein kinase in osteoarthritic cartilage: Evidence for nitric oxide dependence. Osteoarthritis Cartilage 9:294-299.
18. Conery AR, Cao Y, Thompson EA, et al. 2004. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol 6:366-372.
19. Datto MB, Frederick JP, Pan L, et al. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 19:2495-2504.
20. Dunker N, Schuster N, Krieglstein K. 2001. TGF-beta modulates programmed cell death in the retina of the developing chick embryo. Development 128:1933-1942.
21. Estrada KD, Wang WG, Retting KN, et al. 2013. Smad7 regulates terminal maturation of chondrocytes in the growth plate. Dev Biol 382:375-384.
22. Fan Z, Soder S, Oehler S, et al. 2007. Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol 171:938-946.
23. Ford-Hutchinson AF, Ali Z, Lines SE, et al. 2007. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J Bone Miner Res 22:1245-1259.
24. Forsyth CB, Pulai J, Loeser RF. 2002. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 46:2368-2376.
25. Fuentealba LC, Eivers E, Ikeda A, et al. 2007. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131:980-993.
26. Fukai A, Kawamura N, Saito T, et al. 2010. Akt1 in murine chondrocytes controls cartilage calcification during endochondral ossification under physiologic and pathologic conditions. Arthritis Rheum 62:826-836.
27. Gao L, Sheu TJ, Dong Y, et al. 2013. TAK1 regulates Sox9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages. J Cell Sci 126:5704-5713.
28. Gao S, Alarcon C, Sapkota G, et al. 2009. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell 36:457-468.
29. Gordon KJ, Blobe GC. 2008. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782:197-228.
30. Goumans MJ, Valdimarsdottir G, Itoh S, et al. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21:1743-1753.
31. Greenblatt MB, Shim JH, Glimcher LH. 2010. TAK1 mediates BMP signaling in cartilage. Ann NY Acad Sci 1192:385-390.
32. Gronroos E, Kingston IJ, Ramachandran A, et al. 2012. Transforming growth factor beta inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol 32:2904-2916.
33. Gunnell LM, Jonason JH, Loiselle AE, et al. 2010. TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways. J Bone Miner Res 25:1784-1797.
34. Guo X, Wang XF. 2009. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19:71-88.
35. Heyer J, Escalante-Alcalde D, Lia M, et al. 1999. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc Natl Acad Sci USA 96:12595-12600.
36. Hinck AP. 2012. Structural studies of the TGF-betas and their receptors: Insights into evolution of the TGF-beta superfamily. FEBS Lett 586:1860-1870.
37. Hiramatsu K, Iwai T, Yoshikawa H, et al. 2011. Expression of dominant negative TGF-beta receptors inhibits cartilage formation in conditional transgenic mice. J Bone Miner Metab 29:493-500.
38. Holm TM, Habashi JP, Doyle JJ, et al. 2011. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358-361.
39. Horner A, Kemp P, Summers C, et al. 1998. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23:95-102.
40. Hsieh SC, Chen NT, Lo SH. 2009. Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation. Mol Carcinogen 48:545-552.
41. Im HJ, Muddasani P, Natarajan V, et al. 2007. Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes. J Biol Chemistry 282:11110-11121.
42. Inada M, Wang Y, Byrne MH, et al. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 101:17192-17197.
43. Itoh S, Thorikay M, Kowanetz M, et al. 2003. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 278:3751-3761.
44. Iwamoto M, Ohta Y, Larmour C, et al. 2013. Toward regeneration of articular cartilage. Birth Defects Res 99:192-202.
45. Iwata J, Hacia JG, Suzuki A, et al. 2012. Modulation of noncanonical TGF-beta signaling prevents cleft palate in Tgfbr2 mutant mice. J Clin Investig 122:873-885.
46. Kaartinen V, Voncken JW, Shuler CF, et al. 1995. Abnormal lung development and cleft palate in mice lacking TGF-b3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11: 415-421.
47. Karsenty G, Kronenberg HM, Settembre C. 2009. Genetic control of bone formation. Ann Rev Cell Dev Biol 25:629-648.
48. Kawamura I, Maeda, S, Imamura K, et al. 2012. SnoN suppresses maturation of chondrocytes by mediating signal cross-talk between transforming growth factor-beta and bone morphogenetic protein pathways. J Biol Chem 287:29101-29113.
49. Keller B, Yang T, Chen Y, et al. 2011. Interaction of TGFbeta and BMP signaling pathways during chondrogenesis. PloS one 6:e16421.
50. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
51. Kulkarni AB, Karlsson S. 1993. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 143:3-9.
52. Kumar D, Lassar AB. 2009. The transcriptional activity of Sox9 in chondrocytes is regulated by RhoA signaling and actin polymerization. Mol Cell Biol 29:4262-4273.
53. Lamouille S, Derynck R. 2007. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178:437-451.
54. Larsson J, Goumans MJ, Sjostrand LJ, et al. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 20:1663-1673.
55. Las Heras F, Gahunia HK, Pritzker KP. 2012. Articular cartilage development: a molecular perspective. Orthop Clin N Am 43:155-171.
56. Lee JM, Dedhar S, Kalluri R, et al. 2006. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172:973-981.
57. Li TF, Darowish M, Zuscik MJ, et al. 2006. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J Bone Miner Metab 21:4-16.
58. Li TF, Gao L, Sheu TJ, et al. 2010. Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: A potential clinical implication for osteoarthritis. Arthritis Rheum 62:2359-2369.
59. Li TF, O'Keefe RJ, Chen D. 2005. TGF-beta signaling in chondrocytes. Front Biosci 10:681-688.
60. Loeser RF, Forsyth CB, Samarel AM, et al. 2003. Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 278:24577-24585.
61. Long F, Ornitz DM. 2013. Development of the endochondral skeleton. Cold Spring Harbor Perspect Biol 5:a008334.
62. Longobardi L, Li T, Myers TJ, et al. 2012. TGF-beta type II receptor/MCP-5 axis: At the crossroad between joint and growth plate development. Dev Cell 23:71-81.
63. MacLean HE, Kim JI, Glimcher MJ, et al. 2003. Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev Biol 262:51-63.
64. Massague J. 2012a. TGF-beta signaling in development and disease. FEBS Lett 586:1833.
65. Massague J. 2012b. TGFbeta signalling in context. Nat Rev Mol Cell Biol 13:616-630.
66. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev 19:2783-2810.
67. Matsunobu T, Torigoe K, Ishikawa M, et al. 2009. Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol 332:325-338.
68. Millan FA, Denhez F, Kondaiah P, et al. 1991. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111:131-143.
69. Moustakas A, Heldin CH. 2005. Non-Smad TGF-beta signals. J Cell Sci 118:3573-3584.
70. Mu Y, Gudey SK, Landstrom M. 2012. Non-Smad signaling pathways. Cell Tissue Res 347:11-20.
71. Mueller MB, Fischer M, Zellner J, et al. 2010. Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 192:158-166.
72. Mueller MB, Tuan RS. 2008. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58:1377-1388.
73. Murakami S, Balmes G, McKinney S, et al. 2004. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18:290-305.
74. Namdari S, Wei L, Moore D, et al. 2008. Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage. Arthritis Rheum 58:3520-3529.
75. Nomura M, Li E. 1998. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393:786-790.
76. Oshima M, Oshima H, Taketo MM. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179:KC 297-302.
77. Pages G, Guerin S, Grall D, et al. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377.
78. Pan Q, Yu Y, Chen Q, et al. 2008. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol 217:228-241.
79. Pelton RW, Dickinson ME, Moses HL, et al. 1990. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development 110:609-620.
80. Pelton RW, Saxena B, Jones M, et al. 1991. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
81. Pitsillides AA, Beier F. 2011. Cartilage biology in osteoarthritis-Lessons from developmental biology. Nature reviews. Rheumatology 7:654-663.
82. Plaas A, Velasco J, Gorski DJ, et al. 2011. The relationship between fibrogenic TGFbeta1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 19:1081-1090.
83. Poole AR. 2003. Biochemical/immunochemical biomarkers of osteoarthritis: Utility for prediction of incident or progressive osteoarthritis. Rheum Dis Clin N Am 29:803-818.
84. Proetzel G, Pawlowski SA, Wiles MV, et al. 1995. Transforming growth factor beta 3 is required for secondary palate fusion. Nature 11:409-414.
85. Remy I, Montmarquette A, Michnick SW. 2004. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 6:358-365.
86. Rodda SJ, McMahon AP. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133:3231-3244.
87. Rokutanda S, Fujita T, Kanatani N, et al. 2009. Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol 328:78-93.
88. Saba-El-Leil MK, Vella FD, Vernay B, et al. 2003. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4:964-968.
89. Sakou T, Onishi T, Yamamoto T, et al. 1999. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. J Bone Miner Metab 14:1145-1152.
90. Sandberg M, Autio-Harmainen H, Vuorio E. 1988. Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev Biol 130:324-334.
91. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. 1997. TGFβ2 knockout mice have multiple developmental defects that are nonoverlapping with other TGFβ knockout phenotypes. Development 124:2659-2670.
92. Seo HS, Serra R. 2007. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints. Dev Biol 310:304-316.
93. Serra R, Chang C. 2003. TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res Part C 69:333-351.
94. Serra R, Johnson M, Filvaroff EH, et al. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-552.
95. Shapiro IM, Adams CS, Freeman T, et al. 2005. Fate of the hypertrophic chondrocyte: Microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth Defects Res Part C 75:330-339.
96. Shen J, Li J, Wang B, et al. 2013. Deletion of the Type II TGF-beta receptor gene in articular chondrocytes leads to a progressive OA-like phenotype in mice. Arthritis Rheum 65:3107-3119.
97. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
98. Shintani N, Siebenrock KA, Hunziker EB. 2013. TGF-ss1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants and arrests downstream differentiation at an early stage of hypertrophy. PloS one 8:e53086.
99. Shull MM, Ormsby I, Kier AB, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
100. Shull MM, Ormsby I, Kier AB, et al. 1992. Targeted disruption of the mouse transforming growth factor beta-1 gene results in multifocal inflammatory disease. Nature 359:693-699.
101. Song B, Estrada KD, Lyons KM. 2009. Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev 20:379-388.
102. Song JJ, Aswad R, Kanaan RA, et al. 2007. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation. J Cell Physiol 210:398-410.
103. Sorrentino A, Thakur N, Grimsby S, et al. 2008. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199-1207.
104. Spagnoli A, O'Rear L, Chandler RL, et al. 2007. TGF-beta signaling is essential for joint morphogenesis. J Cell Biol 177:1105-1117.
105. Ten Dijke P, Yamashita H, Ichijo H, et al. 1994. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264:101-104.
106. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746.
107. Thorp BH, Anderson I, Jakowlew SB. 1992. Transforming growth factor-beta 1, -beta 2 and -beta 3 in cartilage and bone cells during endochondral ossification in the chick. Development 114:907-911.
108. Tuli R, Tuli S, Nandi S, et al. 2003. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278:41227-41236.
109. van der Kraan PM, Blaney Davidson EN, Blom A, et al. 2009. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: Modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 17:1539-1545.
110. van der Kraan PM, Goumans MJ, Blaney Davidson E, et al. 2012. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res 347:257-265.
111. Waldrip WR, Bikoff EK, Hoodless PA, et al. 1998. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808.
112. Watanabe H, de Caestecker MP, Yamada Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276:14466-14473.
113. Weinstein M, Yang X, Li C, et al. 1998. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci USA 95:9378-9383.
114. Weiss A, Attisano L. 2013. The TGFbeta superfamily signaling pathway. Dev Biol 2:47-63.
115. Woods A, Beier F. 2006. RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J Biol Chem 281:13134-13140.
116. Woods A, Wang G, Beier F. 2005. RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J Biol Chem 280:11626-11634.
117. Wu MY, Hill CS. 2009. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16:329-343.
118. Xu X, Han J, Ito Y, et al. 2008. Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP signaling during tooth and palate development. Dev Cell 15:322-329.
119. Yamaguchi K, Shirakabe K, Shibuya H, et al. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008-2011.
120. Yamashita M, Fatyol K, Jin C, et al. 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31:918-924.
121. Yang G, Sun Q, Teng Y, et al. 2008. PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress. Development 135:3587-3597.
122. Yang X, Chen L, Xu X, et al. 2001. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153:35-46.
123. Yang X, Letterio JJ, Lechleider RJ, et al. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18:1280-1291.
124. Yeganeh B, Mukherjee S, Moir LM, et al. 2013. Novel non-canonical TGF-beta signaling networks: emerging roles in airway smooth muscle phenotype and function. Pulm Pharmacol Therapeut 26:50-63.
125. Yonekura A, Osaki M, Hirota Y, et al. 1999. Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocrine J 46:545-553.
126. Yoon BS, Lyons KM. 2004. Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93:93-103.
127. Yu L, Hebert MC, Zhang YE. 2002. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21:3749-3759.
128. Zhang JH, Tan XH, Li WL, et al. 2005. Smad4 is required for the normal organization of the cartilage growth plate. Dev Biol 284:311-322.
129. Zhang R, Murakami S, Coustry F, et al. 2006. Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. Proc Natl Acad Sci USA 103:365-370.
130. Zhang X, Ziran N, Goater JJ, et al. 2004. Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 34:809-817.
131. Zhang YE. 2009. Non-Smad pathways in TGF-beta signaling. Cell Res 19:128-139.
132. Zhu Y, Richardson JA, Parada LF, et al. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714.